TD POLIO ADSORBED 40 UNIT / 0.5 ML
INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY : 40 UNIT / 0.5 ML DIPHTHERIA TOXOID : 2 LF / 0.5 ML INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT : 32 UNIT / 0.5 ML INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 : 8 UNIT / 0.5 ML TETANUS TOXOID : 5 LF / 0.5 ML · DIN 00615358 · SANOFI PASTEUR LIMITED
Health Canada status: CANCELLED POST MARKET
What is TD POLIO ADSORBED?
TD POLIO ADSORBED 40 UNIT / 0.5 ML contains INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY : 40 UNIT / 0.5 ML DIPHTHERIA TOXOID : 2 LF / 0.5 ML INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT : 32 UNIT / 0.5 ML INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 : 8 UNIT / 0.5 ML TETANUS TOXOID : 5 LF / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 00615358, held by SANOFI PASTEUR LIMITED, supplied as SUSPENSION for INTRAMUSCULAR administration. Health Canada currently lists it as cancelled post market, status dated 30-Sep-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TD POLIO ADSORBED used for?
Active immunization of persons 7 years of age and older for prevention of tetanus, diphtheria and poliomyelitis. Used for primary immunization and boosters.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00615358 |
|---|---|
| Brand name | TD POLIO ADSORBED |
| Generic / active ingredient | INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 1 MAHONEY : 40 UNIT / 0.5 ML DIPHTHERIA TOXOID : 2 LF / 0.5 ML INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 3 SAUKETT : 32 UNIT / 0.5 ML INACTIVATED POLIOMYELITIS VACCINE (D.C.O.) TYPE 2 MEF1 : 8 UNIT / 0.5 ML TETANUS TOXOID : 5 LF / 0.5 ML |
| Manufacturer | SANOFI PASTEUR LIMITED |
| Strength | 40 UNIT / 0.5 ML |
| Dosage form | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J07CA01 DIPHTHERIA-POLIOMYELITIS-TETANUS |
| AHFS class | 80:08.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Sep-2018 |
| Original market date | 1984-12-31 00:00:00 |
How is it administered?
0.5 mL dose. Booster: every 10 years. Primary series (7+ years): 3 doses (first two 2 months apart, third 6-12 months later). Intramuscular injection only.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text (standard vaccine storage usually 2-8°C, but text cuts off).
How is it supplied?
Vial (specific pack sizes not mentioned in text provided).
Contraindications
Known systemic hypersensitivity to any component or after previous administration; acute illness (including febrile illness).
Warnings and precautions
Do not inject into blood vessels or buttocks. Risk of brachial neuritis or Guillain-Barré syndrome. Caution in patients with bleeding disorders. Epinephrine must be available.
What can be used instead?
Other Canadian products sharing ATC code J07CA01 DIPHTHERIA-POLIOMYELITIS-TETANUS. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DT POLIO ADSORBED - SUS IM | 25 LF / 0.5 ML | SUSPENSION | AVENTIS PASTEUR LIMITED | CANCELLED POST MARKET | DIN 02189127 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.